scispace - formally typeset
Open AccessJournal ArticleDOI

Rethinking ovarian cancer: recommendations for improving outcomes

Reads0
Chats0
TLDR
Nine major recommendations that should be taken to improve the outcome for women with ovarian cancer are outlined in this Opinion article.
Abstract
There have been major advances in our understanding of the cellular and molecular biology of the human malignancies that are collectively referred to as ovarian cancer. At a recent Helene Harris Memorial Trust meeting, an international group of researchers considered actions that should be taken to improve the outcome for women with ovarian cancer. Nine major recommendations are outlined in this Opinion article.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopy

TL;DR: CDDP-induced cytostatic effects were associated with a metabolic shift of cancer cells towards accumulation of MRS-detected neutral lipids, whereas the total choline profile failed to be perturbed in both cultured cells and xenografts.
Journal ArticleDOI

Astaxanthin Combine with Human Serum Albumin to Abrogate Cell Proliferation, Migration, and Drug-resistant in Human Ovarian Carcinoma SKOV3 Cells.

TL;DR: Astaxanthin-HSA combined treatment considerably inhibited NF-κB expression and translocation to nucleus, thereby improving the AST-induced cytotoxic effect on SKOV3 cells, and may provide rationale to combine AST with HSA for the treatment of ovarian cancer.
Journal ArticleDOI

Association between ovarian cancer and advanced endometriosis.

TL;DR: In the majority of cases, malignant transformation of endometiosis was observed in endometrioid carcinoma or clear cell carcinoma of the ovary, and further research is required to establish the relationship betweenendometriosis and ovarian cancer.
Journal ArticleDOI

APOBEC3B up-regulation independently predicts ovarian cancer prognosis: a cohort study.

TL;DR: Evaluated the predictive value of APOBEC3B in ovarian cancer clinical outcome, and explored possible molecular mechanisms contributing to ovarian cancer progression, showed that higher APOBec3B expression were an independent prognostic factor to predict both worse overall survival and disease-free survival of ovarian cancer patients.
Journal ArticleDOI

The Histone Methyltransferase DOT1L Is a Functional Component of Estrogen Receptor Alpha Signaling in Ovarian Cancer Cells.

TL;DR: Evidence from loss-of-function genetic screens showing that ERα and DOT1L behave as core fitness factors in OC cells, suggest that combined inhibition of their activity might be effective against ERα-expressing, chemotherapy-resistant ovarian tumors.
References
More filters
Journal ArticleDOI

Cancer-related inflammation.

TL;DR: The molecular pathways of this cancer-related inflammation are now being unravelled, resulting in the identification of new target molecules that could lead to improved diagnosis and treatment.
Journal ArticleDOI

Integrated genomic analyses of ovarian carcinoma

Debra A. Bell, +285 more
- 30 Jun 2011 - 
TL;DR: It is reported that high-grade serous ovarian cancer is characterized by TP53 mutations in almost all tumours (96%); low prevalence but statistically recurrent somatic mutations in nine further genes including NF1, BRCA1,BRCA2, RB1 and CDK12; 113 significant focal DNA copy number aberrations; and promoter methylation events involving 168 genes.

Integrated genomic analyses of ovarian carcinoma

Daphne W. Bell, +261 more
TL;DR: The Cancer Genome Atlas project has analyzed messenger RNA expression, microRNA expression, promoter methylation and DNA copy number in 489 high-grade serous ovarian adenocarcinomas and the DNA sequences of exons from coding genes in 316 of these tumours as mentioned in this paper.
Journal ArticleDOI

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

TL;DR: The presence of intratumoral T cells correlates with improved clinical outcome in advanced ovarian carcinoma and was associated with increased expression of interferon-gamma, interleukin-2, and lymphocyte-attracting chemokines within the tumor.
Related Papers (5)

Integrated genomic analyses of ovarian carcinoma

Debra A. Bell, +285 more
- 30 Jun 2011 -